These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 7617647)

  • 21. p53 expression, mutation, and allelic deletion in ovarian cancer.
    McManus DT; Yap EP; Maxwell P; Russell SE; Toner PG; McGee JO
    J Pathol; 1994 Nov; 174(3):159-68. PubMed ID: 7823248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations.
    Cornelis RS; van Vliet M; Vos CB; Cleton-Jansen AM; van de Vijver MJ; Peterse JL; Khan PM; Børresen AL; Cornelisse CJ; Devilee P
    Cancer Res; 1994 Aug; 54(15):4200-6. PubMed ID: 8033152
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of p53 gene mutation by polymerase chain reaction-single strand conformation polymorphism provides independent prognostic information in node-negative breast cancer.
    Iacopetta B; Grieu F; Powell B; Soong R; McCaul K; Seshadri R
    Clin Cancer Res; 1998 Jul; 4(7):1597-602. PubMed ID: 9676832
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparison of nuclear accumulation of p53 protein with mutations in the p53 gene on the tissues of human breast cancer].
    Fan P; Wu Z; Cha X; Wang X; Wang S
    Zhonghua Wai Ke Za Zhi; 1998 Nov; 36(11):655-7. PubMed ID: 11825490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutant p53 protein overexpression in women with ipsilateral breast tumor recurrence following lumpectomy and radiation therapy.
    Turner BC; Gumbs AA; Carbone CJ; Carter D; Glazer PM; Haffty BG
    Cancer; 2000 Mar; 88(5):1091-8. PubMed ID: 10699900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular diagnosis of p53 mutations in gastric carcinoma by touch preparation.
    Ricevuto E; Ficorella C; Fusco C; Cannita K; Tessitore A; Toniato E; Gabriele A; Frati L; Marchetti P; Gulino A; Martinotti S
    Am J Pathol; 1996 Feb; 148(2):405-13. PubMed ID: 8579104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p53 and Ki-ras gene mutations in epithelial ovarian neoplasms.
    Teneriello MG; Ebina M; Linnoila RI; Henry M; Nash JD; Park RC; Birrer MJ
    Cancer Res; 1993 Jul; 53(13):3103-8. PubMed ID: 8319218
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Greater sensitivity of the PCR-SSCP technique compared with immunohistochemistry for the detection of exon 5 and 6 mutations of gene 53 in breast cancer].
    Dueñas González A; Cruz Hernández JJ; Abad Hernández MM; Ramos M; González Sarmiento R
    Med Clin (Barc); 1996 May; 106(19):721-4. PubMed ID: 8801382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Infrequent p53 gene mutations and lack of p53 protein expression in clear cell sarcoma of the kidney: immunohistochemical study and mutation analysis of p53 in renal tumors of unfavorable prognosis.
    Hsueh C; Wang H; Gonzalez-Crussi F; Lin JN; Hung IJ; Yang CP; Jiang TH
    Mod Pathol; 2002 Jun; 15(6):606-10. PubMed ID: 12065773
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p53 gene alterations in special types of breast carcinoma: a molecular and immunohistochemical study in archival material.
    Karameris AM; Worthy E; Gorgoulis VG; Quezado M; Anastassiades OT
    J Pathol; 1995 Aug; 176(4):361-72. PubMed ID: 7562251
    [TBL] [Abstract][Full Text] [Related]  

  • 31. No evidence for germline mutations in exons 5-9 of the p53 gene in 25 breast cancer families.
    Warren W; Eeles RA; Ponder BA; Easton DF; Averill D; Ponder MA; Anderson K; Evans AM; DeMars R; Love R
    Oncogene; 1992 May; 7(5):1043-6. PubMed ID: 1570151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
    Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
    Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The timing and characterization of p53 mutations in progression from atypical ductal hyperplasia to invasive lesions in the breast cancer.
    Kang JH; Kim SJ; Noh DY; Choe KJ; Lee ES; Kang HS
    J Mol Med (Berl); 2001 Nov; 79(11):648-55. PubMed ID: 11715068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutations in the p53 gene in primary human breast cancers.
    Osborne RJ; Merlo GR; Mitsudomi T; Venesio T; Liscia DS; Cappa AP; Chiba I; Takahashi T; Nau MM; Callahan R
    Cancer Res; 1991 Nov; 51(22):6194-8. PubMed ID: 1682043
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth suppression of human breast cancer cells by the introduction of a wild-type p53 gene.
    Casey G; Lo-Hsueh M; Lopez ME; Vogelstein B; Stanbridge EJ
    Oncogene; 1991 Oct; 6(10):1791-7. PubMed ID: 1923504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. P53 in breast carcinomas: association between presence of mutation and immunohistochemical expression using a semiquantitative approach.
    Schmitt FC; Soares R; Cirnes L; Seruca R
    Pathol Res Pract; 1998; 194(12):815-9. PubMed ID: 9894246
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maintenance of p53 alterations throughout breast cancer progression.
    Davidoff AM; Kerns BJ; Iglehart JD; Marks JR
    Cancer Res; 1991 May; 51(10):2605-10. PubMed ID: 1850660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence that p53 behaves as a tumour suppressor gene in sporadic breast tumours.
    Prosser J; Thompson AM; Cranston G; Evans HJ
    Oncogene; 1990 Oct; 5(10):1573-9. PubMed ID: 2250913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. p53 mutations occur in aggressive breast cancer.
    Mazars R; Spinardi L; BenCheikh M; Simony-Lafontaine J; Jeanteur P; Theillet C
    Cancer Res; 1992 Jul; 52(14):3918-23. PubMed ID: 1617667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p53 gene mutation in primary human renal cell carcinoma.
    Torigoe S; Shuin T; Kubota Y; Horikoshi T; Danenberg K; Danenberg PV
    Oncol Res; 1992; 4(11-12):467-72. PubMed ID: 1299377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.